However, the fact that some of these regions of hypometabolism have been observed in previous studies of single-event TBI in admittedly heterogeneous patient cohorts makes this claim difficult to validate at this time.
The specificity and sensitivity for the cellular immunoblotting assay was similar to those for the islet autoantibody assays performed in the individual workshops and exceeded the specificity and sensitivity of other T-cell assays validated at this time.
However, a significant factor is that there remain a large number of variants in novel genes in the unsolved families that cannot be further validated at this time given the limited size of the current cohort and may represent rare and new causes of ataxia.
However, this idea was not validated at that time by in situ observations probably because of the lack of spacecraft data.
The institution may, if it chooses, set up the validation procedure such that both the device replacing the previously issued device and the additional device are not validated at the time they are issued, and validation will apply to both devices.
A financial institution may issue more than one access device in connection with the renewal or substitution of a previously issued accepted access device, provided that any additional access device (beyond the device replacing the accepted access device) is not validated at the time it is issued, and the institution complies with the other requirements of § 205.5(b).
I saw that Wonder Woman of the '70s validated qualities I had that were not validated at the time anywhere else.
It had however not been validated at the time of publication [ 2].
Institutions are fully validated at the time of the data collection, but as time proceeds, the institutional framework within countries is likely to change, and these changes are not reflected in the database until the next update round.
However, as the interRAI tool had not been validated at the time of the Boyd et al 9 study, it provided limited validation evidence for the BRIGHT instrument.
In this step, the final analysis of the primary and secondary efficacy endpoints up to Week 52 will be performed as well as the safety analysis on all safety data collected and validated at the time of the first analysis.
